University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Coaching and Activity Tracking in Multiple Sclerosis - A Pilot Study

Not Applicable

Completed

Conditions: Multiple Sclerosis

Interventions: Other: Activity Monitoring and Symptom Coaching
Other: Passive Activity Monitoring

First Posted Date: 2017-11-08

Last Posted Date: 2020-08-20

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 30

Registration Number: NCT03335618

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Walnuts to Achieve Lasting NUTrition to Prevent Diabetes

Phase 1

Completed

Conditions: PreDiabetes
Overweight and Obesity

Interventions: Drug: Walnuts

First Posted Date: 2017-11-07

Last Posted Date: 2020-09-02

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 18

Registration Number: NCT03334175

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Kebele Elimination of Trachoma for Ocular Health

Phase 4

Recruiting

Conditions: Trachoma

Interventions: Drug: Azithromycin

First Posted Date: 2017-11-07

Last Posted Date: 2024-03-08

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 320000

Registration Number: NCT03335072

Locations: 🇺🇸
UCSF Proctor Foundation, San Francisco, California, United States
🇪🇹
Eyu-Ethiopia, Bahir Dar, Ethiopia

Living Alone in Old Age With Cognitive Impairment

Active, not recruiting

Conditions: Alzheimer Disease
Living Alone
Mild Cognitive Impairment

First Posted Date: 2017-11-06

Last Posted Date: 2023-11-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 60

Registration Number: NCT03330587

Locations: 🇺🇸
Institute for Health & Aging, San Francisco, California, United States

Activity Trackers for Improving BP

Not Applicable

Completed

Conditions: Physical Activity
Hypertension
Cardiovascular Risk Factor
Chronic Kidney Diseases

Interventions: Device: FitBit

First Posted Date: 2017-10-30

Last Posted Date: 2024-04-02

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 63

Registration Number: NCT03325426

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Daylight Photodynamic Therapy for Actinic Keratosis

Phase 1

Completed

Conditions: Actinic Keratoses

Interventions: Drug: Aminolevulinic Acid Topical 20% Topical Solution
Device: BLU-U blue light phototherapy illuminator

First Posted Date: 2017-10-26

Last Posted Date: 2022-03-09

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 24

Registration Number: NCT03322293

Locations: 🇺🇸
UCSF Dermatology, San Francisco, California, United States

Individualized Studies of Triggers of Paroxysmal Atrial Fibrillation

Not Applicable

Completed

Conditions: Atrial Fibrillation Paroxysmal

Interventions: Behavioral: N-of-1
Behavioral: Data Tracking

First Posted Date: 2017-10-26

Last Posted Date: 2023-11-08

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 499

Registration Number: NCT03323099

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Reducing Pesticide Exposures in Child Care Centers

Not Applicable

Completed

Conditions: Environmental Exposure
Children, Only
Risk Reduction

Interventions: Behavioral: IPM educational workshop and consultation

First Posted Date: 2017-10-24

Last Posted Date: 2024-08-27

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 440

Registration Number: NCT03319927

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Stroke Recovery Initiative - Registry for Stroke Research Studies

Recruiting

Conditions: Acute Stroke
Ischemic Stroke
Cerebral Ischemia
Hemorrhagic Stroke
Subarachnoid Hemorrhage
Cerebral Infarction
Cerebral Vascular Accident
Stroke
Cerebral Stroke

First Posted Date: 2017-10-23

Last Posted Date: 2023-12-04

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 60000

Registration Number: NCT03318432

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma

Early Phase 1

Completed

Conditions: HIV/AIDS
Immunosuppression
Kaposi Sarcoma

Interventions: Drug: Nivolumab

First Posted Date: 2017-10-20

Last Posted Date: 2024-06-25

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 12

Registration Number: NCT03316274

Locations: 🇺🇸
Zuckerberg San Francisco General Hospital, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy